Clinical trials: Attention Deficit Hyperactivity Disorders
Attention Deficit Hyperactivity Disorder
Temperament Dimensions and Awakening Salivary Cortisol Levels in ADHD.
To analyze heterogeneity in ADHD experts in last decade advised to look beyond the lists of existing symptoms towards phenotypic measures that can be represented dimensionally and have well-theorized relationships with…
- Trial name
- NCT04326543
- Testing
- Swanson, Noolan and Phelham - IV edition (SNAP-IV); Conners' Parent Rating Scales (CPRS)
- Where
- 2 sites in Italy
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Università degli Studi di Sassari
Children Aged 6-18 Years With the Diagnosis of ADHD
Clinical Trial: The Efficacy of Janssen's Icon Application (App) in Improving Adherence to Treatment With Stimulant Medications in Children With Attention Deficit/Hyperactivity Disorder
The overarching aim of the study is to assess the efficacy of Janssen's icon Application (App), a digital tool designed to improve adherence to medication treatment in children with ADHD. Our specific hypotheses are: 1.
- Trial name
- App ADHD (NCT06375525)
- Testing
- Janssen's icon Application (App)
- Where
- Israel
- Volunteers
- 39 people
- Sponsor
- Prof. Doron Gothelf MD
ADHD, Exercise
Exercise in Children Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder (ADHD) is a heterogeneous neurodevelopmental disorder characterized by carelessness, hyperactivity and impulsivity, in which genetic, social and physical factors play an important role.
- Trial name
- NCT04279652
- Testing
- Combined exercise
- Where
- Turkey (Türkiye)
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Hacettepe University
Conduct Disorder, Disruptive Behavior Disorder
A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation
The purpose of the study is to assess the effectiveness and safety of an oral solution of risperidone (an antipsychotic medication) versus placebo in the treatment of conduct disorder in children with mild, moderate, or…
- Conditions
- Conduct Disorder, Disruptive Behavior Disorder, Oppositional Defiant Disorder
- Trial name
- NCT00266552
- Testing
- risperidone
- Volunteers
- 118 people
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
ADHD
RCT of EF Family Training for P ADHD
To explore the effect of executive function family training for preschool children with ADHD, providing early social psychological intervention for aiming the core impairments of ADHD.
- Trial name
- NCT04454008
- Testing
- executive function family training, treat as usual
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
ADHD
A Trial of Two-Week Brain Stimulation for Teenagers With ADHD
The objective of this clinical trial is to examine whether non-invasive brain stimulation can modulate dysfunctional brain dynamics underlying adolescent ADHD to subsequently improve clinical symptoms.
- Trial name
- NCT05102864
- Testing
- Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Bradley Hospital
ADHD - Attention Deficit Disorder With Hyperactivity
Parental Stress and Its Relationship With Perceived Social Support and Screen Time Among Caregivers of Children With Attention-Deficit/Hyperactivity Disorder
This study aims to assess parental stress and its relationship with perceived social support and screen time among caregivers of children with Attention Deficit Hyperactivity Disorder (ADHD).
- Trial name
- NCT07790432
- Where
- Egypt
- Volunteers
- 385 people
- Sponsor
- Sohag University
ADHD
Assessment of Neurocognitive Rehabilitations of Inhibition of Disorders in ADHD in Children (ERNTITDAH)
This research aims to assess the cognitives rehabilitations in attention deficit disorder (ADHD) in children. the objective is to demonstrate what are the most relevant cognitive factors for rehabilitative to improve the…
- Trial name
- ERNTITDAH (NCT02405299)
- Testing
- experimental groupe
- Where
- France
- Volunteers
- 60 people
- Sponsor
- L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône
Oppositional Defiant Disorder, Conduct Disorder
Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
This study was developed in order to assess the effects of risperidone (Risperdal) as compared with placebo on cognitive-motor performance (attention, memory, and hand steadiness) and body movements.
- Conditions
- Oppositional Defiant Disorder, Conduct Disorder, Attention Deficit/Hyperactivity Disorder (ADHD), Intermittent Explosive Disorder
- Trial name
- NCT00399698
- Testing
- Risperdal
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Ohio State University
Attention-deficit/Hyperactivity Disorder.
Randomized Controlled Trial With Use of Cognitive Training in Children and Adolescents With ADHD
Purpose: This project assess the effectiveness of a cognitive training as an add-on intervention to drug treatment in children and adolescents diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) compared to a placebo…
- Trial name
- NCT02184598
- Testing
- Cognitive training
- Where
- Brazil
- Volunteers
- 60 people
- Sponsor
- Hospital de Clinicas de Porto Alegre
Attention Deficit Hyperactivity Disorder (ADHD)
Impact of Structured Exercise Programs on Cognitive, Motor and Behavioral Outcomes in Children With ADHD
The purpose of this study is to investigate the effects of structured exercise interventions (Gince Zumba and Square Stepping) on cognitive, motor and behavioral functions of children diagnosed with Attention Deficit…
- Trial name
- ADHD (NCT07376863)
- Testing
- Gince Zumba Exercise, Square Stepping Exercise
- Where
- Turkey (Türkiye)
- Volunteers
- 51 people
- Sponsor
- Cukurova University
Attention Deficit Hyerpactivity Disorder
ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes
Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental condition affecting 5.9% of young people. Late adolescence can be a particularly challenging period for young people with ADHD, with major life…
- Trial name
- ART-transition (NCT07228650)
- Where
- United Kingdom
- Volunteers
- 500 people
- Sponsor
- King's College London
Attention Deficit Disorder With Hyperactivity
Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder
This three-phase study will develop and test a provider-administered intervention to improve medication adherence and promote sustained medication use among children with ADHD and their caregivers.
- Trial name
- NCT00429221
- Testing
- Tailored Medication Messages for Parents
- Volunteers
- healthy volunteers welcome
- Sponsor
- New York State Psychiatric Institute
Attention Deficit Disorder With Hyperactivity
An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
Accumulating evidence suggests a role of G protein-coupled inwardly-rectifying potassium (GIRK) channel in the pathology of excitement of nerve, and the medicine with the action (like the Tipepidine Hibenzate) is expected as a…
- Trial name
- NCT01835093
- Testing
- Tipepidine Hibenzate
- Where
- Japan
- Volunteers
- 10 people
- Sponsor
- Chiba University
ADHD
Managing Young People With ADHD in Primary Care Study
Background: Attention deficit hyperactivity disorder (ADHD) is the most common childhood neurodevelopmental disorder. It affects around 5% of children and adolescents, and up to 40% continue to experience symptoms into adulthood.
- Trial name
- MAP (NCT05518435)
- Testing
- None, observational study
- Where
- United Kingdom
- Volunteers
- 816 people, healthy volunteers welcome
- Sponsor
- University of Exeter
Monoamine Transporter Genes, Environmental Factors
Multimodal Neurobiological Approaches to Explore the Gene-Environment Interactions in ADHD
Previous studies have demonstrated significant associations of attention-deficit hyperactivity disorder (ADHD) with monoamine transporter genes, including dopamine transporter gene (DAT1), norepinephrine transporter gene…
- Trial name
- NCT04571125
- Where
- 2 sites in Taiwan
- Volunteers
- 202 people, healthy volunteers welcome
- Sponsor
- National Taiwan University Hospital
Attention Deficit Hyperactivity Disorder
Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA
This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks.
- Trial name
- NCT00434213
- Testing
- Daytrana
- Where
- 29 sites in United States
- Volunteers
- 309 people
- Sponsor
- Noven Therapeutics
Conduct Disorder, Antisocial Behavior
The Effectiveness of Forensic Outpatient Systemic Therapy: a Multiple Case Experimental Design
The purpose of this study is to investigate the effectiveness and mediators of Forensic Outpatient Systemic Therapy (FAST).
- Conditions
- Conduct Disorder, Antisocial Behavior, Aggression, Behavioral Disorder
- Trial name
- FAST (NCT06032520)
- Testing
- FAST
- Where
- 2 sites in Netherlands
- Volunteers
- 21 people
- Sponsor
- Utrecht University
ADHD
Feasibility Trial of a Guided Internet-delivered Intervention for Adolescents With ADHD
The main aim of this feasibility trial is to investigate the feasibility and preliminary clinical outcomes of a guided digital intervention for adolescents with ADHD.
- Trial name
- NCT06711224
- Testing
- Digital intervention for adolscents with ADHD
- Where
- Norway
- Volunteers
- 60 people
- Sponsor
- Haukeland University Hospital
Attention Deficit Hyperactivity Disorder
Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
For children and adolescents, how does SPD503 compare to placebo for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).
- Trial name
- NCT01244490
- Testing
- Extended-release Guanfacine Hydrochloride, Atomoxetine Hydrochloride
- Where
- 66 sites in United States, Austria and 11 more
- Volunteers
- 338 people
- Sponsor
- Shire
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.